Healthcare Directives

Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients into the United States

This Presidential Proclamation directs adjustments to the importation of patented pharmaceuticals and associated active pharmaceutical ingredients (APIs) based on a finding that current import levels threaten national security by creating overreliance on foreign supply chains for critical medications.

The President imposes a 100% ad valorem tariff on these imports, while simultaneously offering reduced rates (20% or 0%) to companies that commit to or achieve onshoring of production and pricing agreements, and grants zero tariffs to certain specialized pharmaceutical categories.

The action also directs federal departments to pursue negotiation agreements to further secure domestic supply and requires monitoring of generic drug imports, though no immediate tariffs are placed on generics.

Read More

Establishing the Task Force to Eliminate Fraud

This Presidential Action establishes the Task Force to Eliminate Fraud within the Executive Office of the President, chaired by the Vice President, to develop and implement a comprehensive national strategy against fraud, waste, and abuse in federally funded benefit programs administered by states.

The order cites extensive fraud in programs like SNAP and Medicaid, often exacerbated by lax state controls and alleged political motivations, and directs the Task Force to mandate minimum anti-fraud standards, improve eligibility verification, coordinate data sharing, and pursue enforcement actions, including examination of withholding funds from non-compliant jurisdictions.

Read More

Women’s History Month, 2026

President Donald J. Trump issued a proclamation designating March 2026 as Women's History Month, recognizing the diverse and significant achievements of American women throughout the nation's 250-year history.

The proclamation celebrates women in leadership, industry, service, and family roles, while also detailing specific policy actions taken by the administration intended to empower women and families, focusing on economic relief, child-rearing support, and maintaining fair competition in women's sports.

Read More

Ensuring Affordable Beef for the American Consumer

This proclamation, issued by the President on February 6, 2026, temporarily increases the in-quota quantity for certain beef imports, specifically lean beef trimmings, by 80,000 metric tons for the calendar year 2026.

The action is taken under Section 404 of the URAA to combat record-high ground beef prices resulting from a contracting domestic cattle herd, which was impacted by severe regional droughts, wildfire effects, and restrictions on Mexican calf imports.

The entire increased quota is specifically allocated to Argentina and will be administered in four quarterly, first-come, first-served tranches to restore supply and ensure affordable beef prices for American consumers.

Read More

Addressing Addiction through the Great American Recovery Initiative

This Presidential Action establishes the White House Great American Recovery Initiative (Initiative) to elevate and coordinate the national response to the addiction crisis, which affects 16.8 percent of the population and costs the United States hundreds of billions annually.

The Initiative will be co-chaired by the Secretary of Health and Human Services and the Senior Advisor for Addiction Recovery, comprising numerous cabinet-level officials and agency heads.

Its goals include coordinating federal programs, increasing public awareness of addiction as a chronic disease, advising agencies on integrating prevention, treatment, and recovery support across various systems (healthcare, criminal justice, housing), and consulting with state and community partners to advance a national effort toward recovery.

Read More

This document provides a compilation of numerous individuals nominated by the President to various high-level federal positions, including roles within executive departments, independent agencies, ambassadorships, and U.S. Attorney offices.

The listings specify the nominee's name, their proposed role, the agency or location, and often denote whether the appointment is to fill an expired term, a vacancy, or a newly created position, detailing the necessary Senate confirmation required for these appointments to take effect.

Read More

INCREASING MEDICAL MARIJUANA AND CANNABIDIOL RESEARCH

This Presidential Action establishes that Americans deserve better access to medical research on marijuana and cannabidiol (CBD) to address conditions like chronic pain, noting that decades of restrictive federal policy have limited necessary investigations.

The order directs the Attorney General to immediately complete the process of rescheduling marijuana to Schedule III of the Controlled Substances Act (CSA), reflecting the Department of Health and Human Services' recommendation that it has accepted medical use.

Furthermore, the action mandates collaboration with Congress to clarify the regulation of hemp-derived cannabinoid products, including setting THC limits, while tasking HHS and other agencies to develop research models using real-world evidence to improve patient guidance and product safeguards.

Read More

DESIGNATING FENTANYL AS A WEAPON OF MASS DESTRUCTION

A Presidential Action formally designates illicit fentanyl and its core precursor chemicals as Weapons of Mass Destruction (WMD) based on their lethal nature, the national security threat posed by the cartels manufacturing them, and the potential for weaponization.

The order directs relevant executive departments, including Justice, State, Treasury, Defense, and Homeland Security, to take immediate and appropriate actions to implement this designation, involving enhanced investigations, prosecutions, financial sanctions, military support for domestic enforcement, and intelligence gathering using WMD counter-proliferation frameworks.

Read More